Nefrologų pagalba - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 328,349 | 372,579 | 516,368 | 453,323 | 476,114 | 583,059 | 657,458 | 632,766 |
| Profit before tax | 82,266 | 85,452 | 193,796 | 121,646 | 136,656 | 191,971 | 236,545 | 187,327 |
| Net profit | 81,008 | 85,124 | 193,446 | 120,868 | 133,640 | 190,039 | - | 157,135 |
| Equity | 458,408 | 543,532 | 736,978 | 797,846 | 813,486 | 853,525 | 867,975 | 805,109 |
| Liabilities | 206,528 | 127,351 | 22,093 | 59,767 | 54,763 | 48,244 | 38,029 | 67,087 |
| Non-current assets | 620,264 | 604,276 | 596,841 | 636,096 | 634,380 | 617,446 | 589,879 | 560,786 |
| Current assets | 43,550 | 65,470 | 161,052 | 220,596 | 232,735 | 283,005 | 314,679 | 310,049 |
| Total assets | 663,814 | 669,746 | 757,893 | 856,692 | 867,115 | 900,451 | 904,558 | 870,835 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 63,889 | 78,582 | 81,096 |
| Social insurance contributions | - | - | - | - | - | 48,046 | 53,578 | 57,147 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +2.7% | +13.5% | +38.6% | -12.2% | +5.0% | +22.5% | +12.8% | -3.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.2% | 12.7% | 25.5% | 14.1% | 15.4% | 21.1% | - | 18.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 17.7% | 15.7% | 26.2% | 15.1% | 16.4% | 22.3% | - | 19.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 24.7% | 22.8% | 37.5% | 26.7% | 28.1% | 32.6% | - | 24.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 25.1% | 22.9% | 37.5% | 26.8% | 28.7% | 32.9% | 36.0% | 29.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 19,220 | 22,024 | 33,676 | 27,199 | 28,425 | 36,441 | 41,091 | 39,548 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nefrologų pagalba - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-04-19 | 2022-04-20 | 25.63 |
| 2021-11-16 | 2021-11-17 | 0.01 |
Nefrologų pagalba - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-09-29 | 2025-09-30 | 0.03 |
| 2025-09-28 | 2025-09-28 | 47.02 |
| 2025-09-19 | 2025-09-27 | 0.02 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nefrologu pagalba, UAB (code 125652787) is a Private Limited Liability Company operating in medical specialists activities. In 2025, the company generated revenue of EUR 632.8K and net profit of EUR 157.1K, with a profit margin of 24.8%. Revenue declined by 3.8% year on year, after rising from EUR 583.1K in 2023 to EUR 657.5K in 2024, showing a two-year increase of 8.5% despite the latest slowdown. Profitability followed a similar pattern: net profit increased from EUR 190.0K in 2023 to EUR 234.4K in 2024, then eased in 2025. At the end of 2025, total assets stood at EUR 870.8K, equity at EUR 805.1K, and liabilities at EUR 67.1K, indicating a very strong capital position. The equity ratio was 92.5%, debt-to-equity 0.08, ROE 19.5%, and ROA 18.0%. Asset turnover was 0.73x, while revenue per employee reached EUR 39.5K and profit per employee EUR 9.8K.